Search results
Yatra secures corporate travel mandate for pharma giant Cipla - ET TravelWorld
The Economic Times· 3 hours agoYatra Online, India’s largest corporate travel services provider and one of the leading online...
Orchid Pharma rises 4% on deal with Cipla to roll out new UTI drug in India
Business Standard India· 1 day agoThe rise came following Orchid Pharma's announcement of a collaboration with pharmaceutical giant ...
For Cipla, repeated US FDA observations are a cause of concern
Livemint· 4 days agoYet, an adverse report on the third successive inspection of the Goa plant affects its credibility....
Orchid Pharma partners with Cipla to launch new antibiotic in India
Financial Express· 1 day agoCefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract...
Buy Cipla, target price Rs 1700: Motilal Oswal
The Economic Times· 5 days agoCipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 119417.66 Crore) operating in Pharmaceuticals sector.
Orchid Pharma partners with Cipla for distribution of new antibiotics across India - ET HealthWorld...
The Economic Times· 3 days agoNew Delhi, Orchid Pharma Ltd on Friday said it has partnered with Cipla for the launch and...
Cipla - Dissolution Of Wholly Owned Step-Down Subsidiary
CNBC Awaaz· 1 day agoCipla - Dissolution Of Wholly Owned Step-Down Subsidiary
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 5 hours agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
Business Standard India· 3 days agoOrchid Pharma said that it has partnered with Cipla to ensure widespread and rapid distribution of...
Short Call: Bulls take shine to cement stocks, Dr Reddy’s, Cipla, HUL, Fine Organics in focus
CNBC Awaaz· 4 days ago"Lower costs are the handmaiden of higher returns." - John Bogle